Clinico-Pathological Association of Haemoglobin At The Time of Presentation: A Predictive Tool of Survivorship in COVID-19
DOI:
https://doi.org/10.51253/pafmj.v72i1.5840Keywords:
Anemia, COVID-19, Haemoglobin, HaemoglobinopathiesAbstract
Objective: To determine the clinico-pathological association of haemoglobin at the time of presentation as a predictor of survivorship in patients suffering from COVID-19.
Study Design: Prospective observational study.
Place and Duration of Study: Combined Military Hospital Hyderabad Pakistan, from Mar to Sep 2020.
Methodology: Two hundred and four patients who were symptomatic and PCR positive for COVID-19 were included in the study. Informed consent was taken from patients and approval from the institutional ethics committee was obtained. Haemoglobin values were analyzed using SPSS version 22.
Results: In our study, 186 (91.2%) patients survived the disease and 18 (8.8%) patients died. The mortality rate was high in patients who presented with low haemoglobin levels at time of presentation.
Conclusion: This study concluded that hemoglobin level at time of presentation could be a predictor of survivorship.